For Recipients

1 clinical trials · Condition

Record	Firm	Date
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs (NCT02200380)	Celldex Therapeutics	2014-07-01

Every clearance here is in the API, with alerts when new ones post.